Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Intravenous Drug Delivery Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Intravenous Drug Delivery Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Intravenous Drug Delivery Devices market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Intravenous (IV) delivery is an injection or infusion method of drug administration, which means drugs are sent directly into your vein using a needle or tube.
From a downstream perspective, Hospitals accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Intravenous Drug Delivery Devices leading manufacturers including Baxter International, Becton Dickinson and Company, Pfizer, Schott, Johnson & Johnson, Novartis, Novo Nordisk, B. Braun Melsungen AG, Cardinal Health, Teva Pharmaceuticals, etc., dominate supply; the top five capture approximately % of global revenue, with Baxter International leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Intravenous Drug Delivery Devices market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
- Baxter International
- Becton Dickinson and Company
- Pfizer
- Schott
- Johnson & Johnson
- Novartis
- Novo Nordisk
- B. Braun Melsungen AG
- Cardinal Health
- Teva Pharmaceuticals
- Eli Lilly and Company
- Gerresheimer
- Insulet Corporation
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Auto-injectors (Syringe and Cartridge Based)
- Pen Injectors
- Others
Segment by Application
- Hospitals
- Nursing Homes
- Home Care
- Others
Chapter Outline
Chapter 1: Defines the Intravenous Drug Delivery Devices study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
Table of Contents
1 Study Coverage
1.1 Introduction to Intravenous Drug Delivery Devices: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Intravenous Drug Delivery Devices Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Auto-injectors (Syringe and Cartridge Based)
1.2.3 Pen Injectors
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global Intravenous Drug Delivery Devices Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Nursing Homes
1.3.4 Home Care
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Intravenous Drug Delivery Devices Revenue Estimates and Forecasts 2020-2031
2.2 Global Intravenous Drug Delivery Devices Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Intravenous Drug Delivery Devices Sales Estimates and Forecasts 2020-2031
2.4 Global Intravenous Drug Delivery Devices Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Intravenous Drug Delivery Devices Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Intravenous Drug Delivery Devices Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Auto-injectors (Syringe and Cartridge Based) Market Size by Manufacturers
3.5.2 Pen Injectors Market Size by Manufacturers
3.5.3 Others Market Size by Manufacturers
3.6 Global Intravenous Drug Delivery Devices Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Intravenous Drug Delivery Devices Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Intravenous Drug Delivery Devices Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Intravenous Drug Delivery Devices Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Intravenous Drug Delivery Devices Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Intravenous Drug Delivery Devices Sales and Revenue by Type (2020-2031)
6.4 North America Intravenous Drug Delivery Devices Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Intravenous Drug Delivery Devices Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Intravenous Drug Delivery Devices Sales and Revenue by Type (2020-2031)
7.4 Europe Intravenous Drug Delivery Devices Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Intravenous Drug Delivery Devices Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Intravenous Drug Delivery Devices Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Intravenous Drug Delivery Devices Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Intravenous Drug Delivery Devices Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Intravenous Drug Delivery Devices Sales and Revenue by Type (2020-2031)
9.4 Central and South America Intravenous Drug Delivery Devices Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Intravenous Drug Delivery Devices Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Intravenous Drug Delivery Devices Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Intravenous Drug Delivery Devices Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Intravenous Drug Delivery Devices Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Baxter International
11.1.1 Baxter International Corporation Information
11.1.2 Baxter International Business Overview
11.1.3 Baxter International Intravenous Drug Delivery Devices Product Models, Descriptions and Specifications
11.1.4 Baxter International Intravenous Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Baxter International Intravenous Drug Delivery Devices Sales by Product in 2024
11.1.6 Baxter International Intravenous Drug Delivery Devices Sales by Application in 2024
11.1.7 Baxter International Intravenous Drug Delivery Devices Sales by Geographic Area in 2024
11.1.8 Baxter International Intravenous Drug Delivery Devices SWOT Analysis
11.1.9 Baxter International Recent Developments
11.2 Becton Dickinson and Company
11.2.1 Becton Dickinson and Company Corporation Information
11.2.2 Becton Dickinson and Company Business Overview
11.2.3 Becton Dickinson and Company Intravenous Drug Delivery Devices Product Models, Descriptions and Specifications
11.2.4 Becton Dickinson and Company Intravenous Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Becton Dickinson and Company Intravenous Drug Delivery Devices Sales by Product in 2024
11.2.6 Becton Dickinson and Company Intravenous Drug Delivery Devices Sales by Application in 2024
11.2.7 Becton Dickinson and Company Intravenous Drug Delivery Devices Sales by Geographic Area in 2024
11.2.8 Becton Dickinson and Company Intravenous Drug Delivery Devices SWOT Analysis
11.2.9 Becton Dickinson and Company Recent Developments
11.3 Pfizer
11.3.1 Pfizer Corporation Information
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Intravenous Drug Delivery Devices Product Models, Descriptions and Specifications
11.3.4 Pfizer Intravenous Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Pfizer Intravenous Drug Delivery Devices Sales by Product in 2024
11.3.6 Pfizer Intravenous Drug Delivery Devices Sales by Application in 2024
11.3.7 Pfizer Intravenous Drug Delivery Devices Sales by Geographic Area in 2024
11.3.8 Pfizer Intravenous Drug Delivery Devices SWOT Analysis
11.3.9 Pfizer Recent Developments
11.4 Schott
11.4.1 Schott Corporation Information
11.4.2 Schott Business Overview
11.4.3 Schott Intravenous Drug Delivery Devices Product Models, Descriptions and Specifications
11.4.4 Schott Intravenous Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Schott Intravenous Drug Delivery Devices Sales by Product in 2024
11.4.6 Schott Intravenous Drug Delivery Devices Sales by Application in 2024
11.4.7 Schott Intravenous Drug Delivery Devices Sales by Geographic Area in 2024
11.4.8 Schott Intravenous Drug Delivery Devices SWOT Analysis
11.4.9 Schott Recent Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Corporation Information
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Intravenous Drug Delivery Devices Product Models, Descriptions and Specifications
11.5.4 Johnson & Johnson Intravenous Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Johnson & Johnson Intravenous Drug Delivery Devices Sales by Product in 2024
11.5.6 Johnson & Johnson Intravenous Drug Delivery Devices Sales by Application in 2024
11.5.7 Johnson & Johnson Intravenous Drug Delivery Devices Sales by Geographic Area in 2024
11.5.8 Johnson & Johnson Intravenous Drug Delivery Devices SWOT Analysis
11.5.9 Johnson & Johnson Recent Developments
11.6 Novartis
11.6.1 Novartis Corporation Information
11.6.2 Novartis Business Overview
11.6.3 Novartis Intravenous Drug Delivery Devices Product Models, Descriptions and Specifications
11.6.4 Novartis Intravenous Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Novartis Recent Developments
11.7 Novo Nordisk
11.7.1 Novo Nordisk Corporation Information
11.7.2 Novo Nordisk Business Overview
11.7.3 Novo Nordisk Intravenous Drug Delivery Devices Product Models, Descriptions and Specifications
11.7.4 Novo Nordisk Intravenous Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Novo Nordisk Recent Developments
11.8 B. Braun Melsungen AG
11.8.1 B. Braun Melsungen AG Corporation Information
11.8.2 B. Braun Melsungen AG Business Overview
11.8.3 B. Braun Melsungen AG Intravenous Drug Delivery Devices Product Models, Descriptions and Specifications
11.8.4 B. Braun Melsungen AG Intravenous Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 B. Braun Melsungen AG Recent Developments
11.9 Cardinal Health
11.9.1 Cardinal Health Corporation Information
11.9.2 Cardinal Health Business Overview
11.9.3 Cardinal Health Intravenous Drug Delivery Devices Product Models, Descriptions and Specifications
11.9.4 Cardinal Health Intravenous Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Cardinal Health Recent Developments
11.10 Teva Pharmaceuticals
11.10.1 Teva Pharmaceuticals Corporation Information
11.10.2 Teva Pharmaceuticals Business Overview
11.10.3 Teva Pharmaceuticals Intravenous Drug Delivery Devices Product Models, Descriptions and Specifications
11.10.4 Teva Pharmaceuticals Intravenous Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Teva Pharmaceuticals Recent Developments
11.11 Eli Lilly and Company
11.11.1 Eli Lilly and Company Corporation Information
11.11.2 Eli Lilly and Company Business Overview
11.11.3 Eli Lilly and Company Intravenous Drug Delivery Devices Product Models, Descriptions and Specifications
11.11.4 Eli Lilly and Company Intravenous Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Eli Lilly and Company Recent Developments
11.12 Gerresheimer
11.12.1 Gerresheimer Corporation Information
11.12.2 Gerresheimer Business Overview
11.12.3 Gerresheimer Intravenous Drug Delivery Devices Product Models, Descriptions and Specifications
11.12.4 Gerresheimer Intravenous Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Gerresheimer Recent Developments
11.13 Insulet Corporation
11.13.1 Insulet Corporation Corporation Information
11.13.2 Insulet Corporation Business Overview
11.13.3 Insulet Corporation Intravenous Drug Delivery Devices Product Models, Descriptions and Specifications
11.13.4 Insulet Corporation Intravenous Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Insulet Corporation Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Intravenous Drug Delivery Devices Industry Chain
12.2 Intravenous Drug Delivery Devices Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Intravenous Drug Delivery Devices Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Intravenous Drug Delivery Devices Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Intravenous Drug Delivery Devices Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Intravenous Drug Delivery Devices Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
Table of Figures
List of Tables
Table 1. Global Intravenous Drug Delivery Devices Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Intravenous Drug Delivery Devices Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Intravenous Drug Delivery Devices Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Intravenous Drug Delivery Devices Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Intravenous Drug Delivery Devices Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Intravenous Drug Delivery Devices Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Intravenous Drug Delivery Devices Sales by Region (2020-2025) & (K Units)
Table 8. Global Intravenous Drug Delivery Devices Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Intravenous Drug Delivery Devices Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Intravenous Drug Delivery Devices Sales Share by Manufacturers (2020-2025)
Table 12. Global Intravenous Drug Delivery Devices Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Intravenous Drug Delivery Devices Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Intravenous Drug Delivery Devices by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous Drug Delivery Devices as of 2024)
Table 16. Global Intravenous Drug Delivery Devices Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Intravenous Drug Delivery Devices Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Intravenous Drug Delivery Devices Manufacturing Base and Headquarters
Table 19. Global Intravenous Drug Delivery Devices Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Intravenous Drug Delivery Devices Sales by Type (2020-2025) & (K Units)
Table 23. Global Intravenous Drug Delivery Devices Sales by Type (2026-2031) & (K Units)
Table 24. Global Intravenous Drug Delivery Devices Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Intravenous Drug Delivery Devices Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Intravenous Drug Delivery Devices ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Intravenous Drug Delivery Devices Sales by Application (2020-2025) & (K Units)
Table 29. Global Intravenous Drug Delivery Devices Sales by Application (2026-2031) & (K Units)
Table 30. Intravenous Drug Delivery Devices High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Intravenous Drug Delivery Devices Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Intravenous Drug Delivery Devices Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Intravenous Drug Delivery Devices ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Intravenous Drug Delivery Devices Growth Accelerators and Market Barriers
Table 37. North America Intravenous Drug Delivery Devices Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Intravenous Drug Delivery Devices Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Intravenous Drug Delivery Devices Growth Accelerators and Market Barriers
Table 40. Europe Intravenous Drug Delivery Devices Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Intravenous Drug Delivery Devices Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Intravenous Drug Delivery Devices Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Intravenous Drug Delivery Devices Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Intravenous Drug Delivery Devices Growth Accelerators and Market Barriers
Table 45. Southeast Asia Intravenous Drug Delivery Devices Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Intravenous Drug Delivery Devices Investment Opportunities and Key Challenges
Table 47. Central and South America Intravenous Drug Delivery Devices Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Intravenous Drug Delivery Devices Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Intravenous Drug Delivery Devices Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Baxter International Corporation Information
Table 51. Baxter International Description and Major Businesses
Table 52. Baxter International Product Models, Descriptions and Specifications
Table 53. Baxter International Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Baxter International Sales Value Proportion by Product in 2024
Table 55. Baxter International Sales Value Proportion by Application in 2024
Table 56. Baxter International Sales Value Proportion by Geographic Area in 2024
Table 57. Baxter International Intravenous Drug Delivery Devices SWOT Analysis
Table 58. Baxter International Recent Developments
Table 59. Becton Dickinson and Company Corporation Information
Table 60. Becton Dickinson and Company Description and Major Businesses
Table 61. Becton Dickinson and Company Product Models, Descriptions and Specifications
Table 62. Becton Dickinson and Company Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Becton Dickinson and Company Sales Value Proportion by Product in 2024
Table 64. Becton Dickinson and Company Sales Value Proportion by Application in 2024
Table 65. Becton Dickinson and Company Sales Value Proportion by Geographic Area in 2024
Table 66. Becton Dickinson and Company Intravenous Drug Delivery Devices SWOT Analysis
Table 67. Becton Dickinson and Company Recent Developments
Table 68. Pfizer Corporation Information
Table 69. Pfizer Description and Major Businesses
Table 70. Pfizer Product Models, Descriptions and Specifications
Table 71. Pfizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Pfizer Sales Value Proportion by Product in 2024
Table 73. Pfizer Sales Value Proportion by Application in 2024
Table 74. Pfizer Sales Value Proportion by Geographic Area in 2024
Table 75. Pfizer Intravenous Drug Delivery Devices SWOT Analysis
Table 76. Pfizer Recent Developments
Table 77. Schott Corporation Information
Table 78. Schott Description and Major Businesses
Table 79. Schott Product Models, Descriptions and Specifications
Table 80. Schott Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Schott Sales Value Proportion by Product in 2024
Table 82. Schott Sales Value Proportion by Application in 2024
Table 83. Schott Sales Value Proportion by Geographic Area in 2024
Table 84. Schott Intravenous Drug Delivery Devices SWOT Analysis
Table 85. Schott Recent Developments
Table 86. Johnson & Johnson Corporation Information
Table 87. Johnson & Johnson Description and Major Businesses
Table 88. Johnson & Johnson Product Models, Descriptions and Specifications
Table 89. Johnson & Johnson Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Johnson & Johnson Sales Value Proportion by Product in 2024
Table 91. Johnson & Johnson Sales Value Proportion by Application in 2024
Table 92. Johnson & Johnson Sales Value Proportion by Geographic Area in 2024
Table 93. Johnson & Johnson Intravenous Drug Delivery Devices SWOT Analysis
Table 94. Johnson & Johnson Recent Developments
Table 95. Novartis Corporation Information
Table 96. Novartis Description and Major Businesses
Table 97. Novartis Product Models, Descriptions and Specifications
Table 98. Novartis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Novartis Recent Developments
Table 100. Novo Nordisk Corporation Information
Table 101. Novo Nordisk Description and Major Businesses
Table 102. Novo Nordisk Product Models, Descriptions and Specifications
Table 103. Novo Nordisk Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Novo Nordisk Recent Developments
Table 105. B. Braun Melsungen AG Corporation Information
Table 106. B. Braun Melsungen AG Description and Major Businesses
Table 107. B. Braun Melsungen AG Product Models, Descriptions and Specifications
Table 108. B. Braun Melsungen AG Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. B. Braun Melsungen AG Recent Developments
Table 110. Cardinal Health Corporation Information
Table 111. Cardinal Health Description and Major Businesses
Table 112. Cardinal Health Product Models, Descriptions and Specifications
Table 113. Cardinal Health Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Cardinal Health Recent Developments
Table 115. Teva Pharmaceuticals Corporation Information
Table 116. Teva Pharmaceuticals Description and Major Businesses
Table 117. Teva Pharmaceuticals Product Models, Descriptions and Specifications
Table 118. Teva Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Teva Pharmaceuticals Recent Developments
Table 120. Eli Lilly and Company Corporation Information
Table 121. Eli Lilly and Company Description and Major Businesses
Table 122. Eli Lilly and Company Product Models, Descriptions and Specifications
Table 123. Eli Lilly and Company Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Eli Lilly and Company Recent Developments
Table 125. Gerresheimer Corporation Information
Table 126. Gerresheimer Description and Major Businesses
Table 127. Gerresheimer Product Models, Descriptions and Specifications
Table 128. Gerresheimer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Gerresheimer Recent Developments
Table 130. Insulet Corporation Corporation Information
Table 131. Insulet Corporation Description and Major Businesses
Table 132. Insulet Corporation Product Models, Descriptions and Specifications
Table 133. Insulet Corporation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Insulet Corporation Recent Developments
Table 135. Key Raw Materials Distribution
Table 136. Raw Materials Key Suppliers
Table 137. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 138. Milestones in Production Technology Evolution
Table 139. Distributors List
Table 140. Market Trends and Market Evolution
Table 141. Market Drivers and Opportunities
Table 142. Market Challenges, Risks, and Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Intravenous Drug Delivery Devices Product Picture
Figure 2. Global Intravenous Drug Delivery Devices Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Auto-injectors (Syringe and Cartridge Based) Product Picture
Figure 4. Pen Injectors Product Picture
Figure 5. Others Product Picture
Figure 6. Global Intravenous Drug Delivery Devices Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Hospitals
Figure 8. Nursing Homes
Figure 9. Home Care
Figure 10. Others
Figure 11. Intravenous Drug Delivery Devices Report Years Considered
Figure 12. Global Intravenous Drug Delivery Devices Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Intravenous Drug Delivery Devices Revenue (2020-2031) & (US$ Million)
Figure 14. Global Intravenous Drug Delivery Devices Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Intravenous Drug Delivery Devices Revenue Market Share by Region (2020-2031)
Figure 16. Global Intravenous Drug Delivery Devices Sales (2020-2031) & (K Units)
Figure 17. Global Intravenous Drug Delivery Devices Sales (CAGR) by Region (2020-2031) (K Units)
Figure 18. Global Intravenous Drug Delivery Devices Sales Market Share by Region (2020-2031)
Figure 19. Top 5 and Top 10 Manufacturers Intravenous Drug Delivery Devices Sales Volume Market Share in 2024
Figure 20. Global Intravenous Drug Delivery Devices Revenue Market Share Ranking (2024)
Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 22. Auto-injectors (Syringe and Cartridge Based) Revenue Market Share by Manufacturer in 2024
Figure 23. Pen Injectors Revenue Market Share by Manufacturer in 2024
Figure 24. Others Revenue Market Share by Manufacturer in 2024
Figure 25. Global Intravenous Drug Delivery Devices Sales Market Share by Type (2020-2031)
Figure 26. Global Intravenous Drug Delivery Devices Revenue Market Share by Type (2020-2031)
Figure 27. Global Intravenous Drug Delivery Devices Sales Market Share by Application (2020-2031)
Figure 28. Global Intravenous Drug Delivery Devices Revenue Market Share by Application (2020-2031)
Figure 29. North America Intravenous Drug Delivery Devices Sales YoY (2020-2031) & (K Units)
Figure 30. North America Intravenous Drug Delivery Devices Revenue YoY (2020-2031) & (US$ Million)
Figure 31. North America Top 5 Manufacturers Intravenous Drug Delivery Devices Sales Revenue (US$ Million) in 2024
Figure 32. North America Intravenous Drug Delivery Devices Sales Volume (K Units) by Type (2020- 2031)
Figure 33. North America Intravenous Drug Delivery Devices Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 34. North America Intravenous Drug Delivery Devices Sales Volume (K Units) by Application (2020-2031)
Figure 35. North America Intravenous Drug Delivery Devices Sales Revenue (US$ Million) by Application (2020-2031)
Figure 36. US Intravenous Drug Delivery Devices Revenue (2020-2031) & (US$ Million)
Figure 37. Canada Intravenous Drug Delivery Devices Revenue (2020-2031) & (US$ Million)
Figure 38. Mexico Intravenous Drug Delivery Devices Revenue (2020-2031) & (US$ Million)
Figure 39. Europe Intravenous Drug Delivery Devices Sales YoY (2020-2031) & (K Units)
Figure 40. Europe Intravenous Drug Delivery Devices Revenue YoY (2020-2031) & (US$ Million)
Figure 41. Europe Top 5 Manufacturers Intravenous Drug Delivery Devices Sales Revenue (US$ Million) in 2024
Figure 42. Europe Intravenous Drug Delivery Devices Sales Volume (K Units) by Type (2020-2031)
Figure 43. Europe Intravenous Drug Delivery Devices Sales Revenue (US$ Million) by Type (2020-2031)
Figure 44. Europe Intravenous Drug Delivery Devices Sales Volume (K Units) by Application (2020-2031)
Figure 45. Europe Intravenous Drug Delivery Devices Sales Revenue (US$ Million) by Application (2020-2031)
Figure 46. Germany Intravenous Drug Delivery Devices Revenue (2020-2031) & (US$ Million)
Figure 47. France Intravenous Drug Delivery Devices Revenue (2020-2031) & (US$ Million)
Figure 48. U.K. Intravenous Drug Delivery Devices Revenue (2020-2031) & (US$ Million)
Figure 49. Italy Intravenous Drug Delivery Devices Revenue (2020-2031) & (US$ Million)
Figure 50. Russia Intravenous Drug Delivery Devices Revenue (2020-2031) & (US$ Million)
Figure 51. Asia-Pacific Intravenous Drug Delivery Devices Sales YoY (2020-2031) & (K Units)
Figure 52. Asia-Pacific Intravenous Drug Delivery Devices Revenue YoY (2020-2031) & (US$ Million)
Figure 53. Asia-Pacific Top 8 Manufacturers Intravenous Drug Delivery Devices Sales Revenue (US$ Million) in 2024
Figure 54. Asia-Pacific Intravenous Drug Delivery Devices Sales Volume (K Units) by Type (2020- 2031)
Figure 55. Asia-Pacific Intravenous Drug Delivery Devices Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 56. Asia-Pacific Intravenous Drug Delivery Devices Sales Volume (K Units) by Application (2020-2031)
Figure 57. Asia-Pacific Intravenous Drug Delivery Devices Sales Revenue (US$ Million) by Application (2020-2031)
Figure 58. Indonesia Intravenous Drug Delivery Devices Revenue (2020-2031) & (US$ Million)
Figure 59. Japan Intravenous Drug Delivery Devices Revenue (2020-2031) & (US$ Million)
Figure 60. South Korea Intravenous Drug Delivery Devices Revenue (2020-2031) & (US$ Million)
Figure 61. China Taiwan Intravenous Drug Delivery Devices Revenue (2020-2031) & (US$ Million)
Figure 62. India Intravenous Drug Delivery Devices Revenue (2020-2031) & (US$ Million)
Figure 63. Central and South America Intravenous Drug Delivery Devices Sales YoY (2020-2031) & (K Units)
Figure 64. Central and South America Intravenous Drug Delivery Devices Revenue YoY (2020-2031) & (US$ Million)
Figure 65. Central and South America Top 5 Manufacturers Intravenous Drug Delivery Devices Sales Revenue (US$ Million) in 2024
Figure 66. Central and South America Intravenous Drug Delivery Devices Sales Volume (K Units) by Type (2021-2031)
Figure 67. Central and South America Intravenous Drug Delivery Devices Sales Revenue (US$ Million) by Type (2020-2031)
Figure 68. Central and South America Intravenous Drug Delivery Devices Sales Volume (K Units) by Application (2020-2031)
Figure 69. Central and South America Intravenous Drug Delivery Devices Sales Revenue (US$ Million) by Application (2020-2031)
Figure 70. Brazil Intravenous Drug Delivery Devices Revenue (2020-2025) & (US$ Million)
Figure 71. Argentina Intravenous Drug Delivery Devices Revenue (2020-2025) & (US$ Million)
Figure 72. Middle East, and Africa Intravenous Drug Delivery Devices Sales YoY (2020-2031) & (K Units)
Figure 73. Middle East and Africa Intravenous Drug Delivery Devices Revenue YoY (2020-2031) & (US$ Million)
Figure 74. Middle East and Africa Top 5 Manufacturers Intravenous Drug Delivery Devices Sales Revenue (US$ Million) in 2024
Figure 75. Middle East and Africa Intravenous Drug Delivery Devices Sales Volume (K Units) by Type (2021-2031)
Figure 76. South America Intravenous Drug Delivery Devices Sales Revenue (US$ Million) by Type (2020-2031)
Figure 77. Middle East and Africa Intravenous Drug Delivery Devices Sales Volume (K Units) by Application (2020-2031)
Figure 78. Middle East and Africa Intravenous Drug Delivery Devices Sales Revenue (US$ Million) by Application (2020-2031)
Figure 79. GCC Countries Intravenous Drug Delivery Devices Revenue (2020-2025) & (US$ Million)
Figure 80. Turkey Intravenous Drug Delivery Devices Revenue (2020-2025) & (US$ Million)
Figure 81. Egypt Intravenous Drug Delivery Devices Revenue (2020-2025) & (US$ Million)
Figure 82. South Africa Intravenous Drug Delivery Devices Revenue (2020-2025) & (US$ Million)
Figure 83. Intravenous Drug Delivery Devices Industry Chain Mapping
Figure 84. Regional Intravenous Drug Delivery Devices Manufacturing Base Distribution (%)
Figure 85. Global Intravenous Drug Delivery Devices Production Market Share by Region (2020-2031)
Figure 86. Intravenous Drug Delivery Devices Production Process
Figure 87. Regional Intravenous Drug Delivery Devices Production Cost Structure
Figure 88. Channels of Distribution (Direct Vs Distribution)
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed
Related Reports
Global Intravenous Drug Delivery Devices Market Research Report 2024
Intravenous (IV) delivery is an injection or infusion method of drug administration, which means drugs are sent directly into your vein using a needle or tube.
Published Date: 2024-01-17
Pages: 88
USD 2900.00
(Single User License)
Global Intravenous Drug Delivery Devices Market Research Report 2025
The global market for Intravenous Drug Delivery Devices was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-13
Pages: 89
USD 2900.00
(Single User License)
Intravenous Drug Delivery Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Intravenous Drug Delivery Devices was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 121
USD 3950.00
(Single User License)
Global Intravenous Drug Delivery Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Intravenous Drug Delivery Devices market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 91
USD 4250.00
(Single User License)
Global Intravenous Drug Delivery Devices Market Research Report 2026
The global Intravenous Drug Delivery Devices market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-17
Pages: 124
USD 2900.00
(Single User License)
Intravenous Drug Delivery Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Intravenous Drug Delivery Devices was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 140
USD 3950.00
(Single User License)
Global Intravenous Drug Delivery Devices Market Research Report 2024
Intravenous (IV) delivery is an injection or infusion method of drug administration, which means drugs are sent directly into your vein using a needle or tube.
Published: 2024-01-17
Pages: 88
USD 2900.00 (Single User License)Global Intravenous Drug Delivery Devices Market Research Report 2025
The global market for Intravenous Drug Delivery Devices was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-13
Pages: 89
USD 2900.00 (Single User License)Intravenous Drug Delivery Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Intravenous Drug Delivery Devices was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 121
USD 3950.00 (Single User License)Global Intravenous Drug Delivery Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Intravenous Drug Delivery Devices market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 91
USD 4250.00 (Single User License)Global Intravenous Drug Delivery Devices Market Research Report 2026
The global Intravenous Drug Delivery Devices market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-17
Pages: 124
USD 2900.00 (Single User License)Intravenous Drug Delivery Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Intravenous Drug Delivery Devices was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 140
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
Market Segmentation
Why This Report?
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
Interest In This Report?
Get A Free Sample
Pre-Order Enquiry
OR
Need a Tailored Report?
Customize this report to your needs.
Customize This Report
Fact Checked
Cite this Research